Case Report: Paradoxical Inflammatory Response Syndrome in a Previously Healthy, HIV-Negative, Pediatric Patient With Cryptococcus gatii Meningitis
Related Experiment Video
Updated: Sep 17, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Jessica H Cheng1, Ritu Cheema2, Peter R Williamson3
1Department of Pediatrics, UC Davis Health, Sacramento, CA, United States.
Abstract:
The immunological response of patients with cryptococcal meningitis (CM), particularly those not known to be immunocompromised, has generated an increased interest recently. Although CM is an infection with significant rates of morbidity and mortality, its sequelae may also include a post-infectious inflammatory response syndrome (PIIRS) in patients who have already achieved microbiological control. PIIRS can cause substantial immune-mediated damage to the central nervous system resulting in long-term neurological disability or even death. Steroids have been used successfully in the management of PIIRS in adults. In this report, we present the case of a previously healthy adolescent male with Cryptococcus gattii meningitis who experienced neurological deterioration due to PIIRS after the initiation of antifungal therapy. Immunological workup did not demonstrate any frank underlying immunodeficiencies, and genetic primary immunodeficiency screening was unremarkable. He was treated with steroids and recovered clinically; however, intermittent inflammatory episodes needed to be managed through several flares of symptoms. In the setting of the current literature, we discuss the management and monitoring of PIIRS in a pediatric patient, along with considerations of targeted future therapies.
Insights
A rare inflammatory syndrome (PIIRS) can occur after cryptococcal meningitis (CM) treatment, even in healthy individuals. Steroids helped manage this in a pediatric case, highlighting the need for careful monitoring and future therapies.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Pediatric Neurology
Background:
- Cryptococcal meningitis (CM) presents significant morbidity and mortality.
- Post-infectious inflammatory response syndrome (PIIRS) is a serious sequela of CM, causing immune-mediated CNS damage.
- PIIRS management in pediatric patients, especially those not immunocompromised, requires further investigation.
Observation:
- A previously healthy adolescent male with *Cryptococcus gattii* meningitis developed neurological deterioration due to PIIRS after antifungal therapy.
- Immunological workup, including genetic screening, did not reveal underlying immunodeficiencies.
- The patient experienced clinical recovery with steroid treatment, but required management for recurrent inflammatory episodes.
Findings:
- Steroid therapy demonstrated efficacy in managing PIIRS in this pediatric case.
- The case underscores the potential for PIIRS in immunocompetent individuals following CM.
- Successful management involved addressing intermittent inflammatory flares.
Implications:
- This case highlights the importance of recognizing and managing PIIRS in pediatric cryptococcal meningitis.
- Steroids represent a viable treatment option for PIIRS in children.
- Further research into targeted therapies for PIIRS is warranted to prevent long-term neurological sequelae.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Rocky Mountain Spotted Fever
Bacterial Meningitis
Cryptococcal Meningitis
Toxoplasmosis
Bacterial Meningitis II: Pathophysiology

